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1. Introduction 
Malonyl-CoA, an intermediate in the fatty acid 
synthesis pathway, has been reported as a potent 
inhibitor of carnitlne palmitoyltransferase I. Thus it 
has been postulated that this compound plays a 
central role in the regulation of fatty acid oxidation 
and ketogenesis [ 1-3 1. 
We have reported that glucagon significantly 
stimulates the oxidation of fatty acids in hepatocytes 
isolated from fed or fasted-carbohydrate refed rats 
[4]. The high rates of fatty acid oxidation, in 
glucagon-stimulated c lls, were accompanied by an 
increase in the level of long-chain acyl-CoA (most 
probably the extramitochondrlal pool) and long-chain 
acylcarnitines [4]. It is difficult to explain these 
observations exclusively by an increase in the activity 
of carnitine palmitoyltransferase I due to lowered 
concentration of malonyl-CoA in the glucagon-stimu- 
lated cells. 
Here the effect of a series of known antiketogenic 
agents and pyruvate on the oxidation of palmitate, in 
control and glucagon-stimulated c lls, was investigated. 
The changes in the level of long-chain acyl-CoA, long- 
chain acylcarnitines and sn-3glycerophosphate under 
different rates of fatty acid oxidation were deter- 
mined. It has been found that the steady-state con- 
centrations of long-chain acylcarnitines and long-chain 
acyl-CoA are positively correlated with the rates of 
palmitate oxidation under the conditions tudied. It 
is suggested that an important regulatory site in the 
esterification pathway contributes to the regulation 
of fatty acid oxidation in the liver through the changes 
in the level of extramitochondrial cyl-CoA. 
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2. Materials and methods 
[ I-?]Palmitate was obtained fron NEM Chemicals 
GmbH, FRG. - [methyZ-3H]Carnitine was prepared 
according to [S 1. Essentially fatty acid free bovine 
serum albumin, coenzyme A, palmitoyl-CoA, 
P-hydroxybutyrate dehydrogenase and sn-3glycero- 
phosphate dehydrogenase w re purchased from Sigma 
Chemical Co, St Louis, MO. Other reagents used were 
of highest purity available. 
The hepatocytes were isolated, from rats fed a usual 
laboratory diet, according to [6 1. Ca*+-free Krebs- 
Henseleit bicarbonate buffer was used as a suspension 
and incubation medium. The incubation was started 
by addition of 1 ml cell suspension (S-7 mg protein) 
to 1 ml buffer containing 0.58 mM bovine serum 
albumin and either 0.5 mM [ 1 -i4C Jpalmitate (SO0 cpm/ 
nmol) and 0.5 mM non-labelled carnitine or 0.5 mM 
palmitate and 0.5 mM [3H]carnitine (4000 cpm/nmol) 
if not indicated otherwise. When present, lactate, 
pyruvate, ethanol, sorbitol and dihydroxyacetone 
were added to 10 mM, fructose to S mM, glycerol to 
7.5 mM and glucagon to 4 X lo-* M. All the deter- 
minations were made after 30 min incubation at 37°C 
since the rates of fatty acid oxidation and ketogenesis 
have been found to be linear for at least 1 h under the 
conditions used [4]. The measurements of acid-soluble 
products, ‘TO*, total ketone bodies, long-chain acyl- 
camitines and long-chain acyl-CoA were done as in 
[4-71. sn-3-Glycerophosphate was determined with 
sn-3glycerophosphate d hydrogenase. Carnitine was 
determined according to [8]; protein by the Lowry 
method [9]. 
The results are presented as mean + SEM from 
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3-5 cell prep~ations. Student’s t-test has been used 
for the statistical treatment of the results. 
3. Results and discussion 
Table 1 shows that all of the antiketogenic agents 
used in the experiments moderately decreased the 
rate of fatty acid oxidation in control hepatocytes 
isolated from fed rats. However, their inhibitory 
effects became apparent after the oxidation rate of 
palmitate had been st~ulated by glucagon. All the 
agents used, except for pyruvate, increased the con- 
centration of so-3~ycerophosphate but to very 
different degrees, in agreement with [lo]. 
The extent of inhibition of pahnitate oxidation (to 
acid soluble products and COJ by different anti- 
ketogenic agents was very similar (39-47%) in spite 
of their different effects on sn-3glycerophosphate 
concentration and redox situation both in the cyto- 
plasm and in the mitochondria (note that paired sub- 
strates oxj~zed~reduced were used). This does not 
exclude the possibility that under certain conditions 
the &ncentration of sn-3-glycerophosphate may be 
rate-limiting for esterification. Glucagon decreased 
significantly the concentration of sn-3-glycerophos- 
phate under all conditions except in the presence of 
glycerol, when the concentration of sn3.glycerophos- 
phate was extremely high (table 1). The Km value for 
sn-3glycerophosphate cyltransferase r ported in the 
literature varies from 0.1-l mM [ 1 l-l 33. The 
observed concentration of this substrate was 0.86 mM 
in control cells and was decreased in the presence of 
glucagon to 0.46 mM (assu~ng the ~tracellular 
volume of 3 pl/mg protein [ 141). Thus, it is difficult 
to predict how much influence such variations in 
sn-3glycerophospkate concentration might have on 
the activity of glycerophosphate acyltransferase. 
Tab.bie 1 and fig.1 A show that there is a good 
correlation between the rate of palmitate oxidation 
and the level of long-chain acylcarnitines. The latter 
has b,een,showp to’vary depending on the intracellular 
Table 1 
The effect of antiketogeni~ agents and pyruvate on the metabolism of pah&ate in isolated hepatocytes 
Additions Acid-soluble 
products 
WO, Total ketone Long-chain Long-chain sn3-glycero- 
bodies acyl-CoA acylcarnitine phosphate 
Xl0 x 10 
A None 
Lactate 
Pyruvate 
Glycerol 
Dihydroxy- 
acetone 
Sorbitol 
Fructose 
Ethanol 
B None 
Lactate 
Pyruvate 
Glycerol 
Dihydroxy- 
acetone 
Sorbitol 
Fructose 
Ethanol 
14.7 (0.5) 
12.7 (0.2) 
18.1 (0.3) 
14.0 (0.4) 
13.6 (0.2) 
13.6 (0.2) 
13.3 (0.2) 
17.2 (0.5) 
5.8 (0.3) 
4.6 (0.2) 
7.1 (0.4) 
1.8 (0.1) 
3.6 (0.2) 
2.8 (0.1) 
4.1 (0.1) 
0.9 (0.1) 
29.8 (0.6)a 7.3 
(0.8)d 
(0.3)C 
14.2 6.0 (0.3)b 
3 1.2 (0.6)a 7.6 (0.3jd 
17.0 (0.4)a 3.2 (O.f)a 
15.0 (0.2)a 
16.2 (0.6jb 
15.4 (0.4)a 
21.4 (0.4)a 
4.7 (O.l)a 
3.6 (O.l)a 
5.6 (O.lja 
1.2 (O.l)d 
88.4 (1.7) 
72.4 (0.9) 
125.8 (1.9) 
82.2 (1.3) 
78.0 (1.2) 
71.8 (0.9) 
78.0 (0.8) 
133.8 (2.0) 
198.6 (4.1)a 
81.0 (l.O)a 
220.0 (4.8)a 
93.2(\:2)a 
84.0 (ti.8jb 
86.3 (0.9)a 
84.4 (0.8)a 
150.5 (2.l)a 
14.1 (1.0) 
12.2 (0.8) 
18.3 (1.1) 
8.3 (0.4) 
11.1 (0.6) 
9.0 (0.3) 
10.0 (0.4) 
10.5 (0.5) 
24.0 (l.3)a 
16.3 (l.O)c 
262 (1.2)a 
10.0 (0.4)C 
14.2 (0.5jb 
10.8 (0.3)b 
11.4 (0.2)C 
13.2 (0.4jb 
22.1 (0.8) 
14.0 (0.3) 
22.3 (0.7) 
12.1 (0.3) 
15.2 (0.4) 
12.0 (0.3) 
15.1 (0.3) 
16.2 (0.3) 
41.3 (0.9)a 
15.1 (0.3jC 
42.1 (l.O)a 
14.0 (0.4)b 
19.3 (0.3)a 
14.0 (0.3)a 
16.0 (0.2)c 
20.1 (0.3)a 
2.58 (0.17) 
3.40 (0.12) 
1.09 (0.09) 
65.2 (2.75) 
6.90 (0.36) 
17.90 (0.48) 
2.96 (0.15) 
19.60 (1.25) 
1.39 {0.08)a 
2.00 (o.os)a 
< 0.7 
60.30 (2.40)d 
3.20 (0.30)a 
9.50 (0.75)a 
2.10 (0.07)8 
10.70 (0.9)a 
Different from the results obtained in the absence of ghmagon with: ap < 0.005, bp < 0.01, “p < 0.05, dp > 0.05, NS 
Acid-soluble products and ‘%O, are expressed in nmol ( l-‘~]pa~i~te. mg protein’ ‘, other results in nmol. mg protein-‘. (A) in 
the absence of ghmagon; (B) in the presence of glucagon 
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IA1 
Long-&m acyl-CoA linolxmg pmlaon-’ I 
Fig.1. A. The correlation between the rate of palmitate oxida- 
tion and the level of long-chain acylcarnitines in the liver cells. 
B. The correlation between the rate of palmitate oxidation and 
the level of long-chain acylCoA in the liver cells. C. The cor- 
relation between the level of long-chain acylcamitines and 
long-chain acylCoA in the liver cells. The results are the same 
as in table 1. The rate of palmitate oxidation is the sum of 
palmitate oxidized to acid-soluble products and “CO,. 
Linear regression analysis has been used to calculate correla- 
tion coefficients (r), interception and the slope. Open symbols, 
in the presence of glucagon; closed symbols, in the absence of 
glucagon. 
concentration of carnitine [ 141 and the concentra- 
tion of palmitate in the medium [4]. Under the con- 
ditions used in the present experiments, the concen- 
tration of intracellular carnitine and pahnitate in the 
medium were approximately equal at a given time 
point in all the samples. The rate of pahnitate uptake 
was almost identical under all conditions since the 
changes in the rates of oxidation were balanced by 
the changes in the rates of triacylglycerol synthesis 
(not shown). The carnitine transport into the cells is 
not significantly influenced by added agents since a 
specific carrier for carnitine transport apparently 
exists in the plasma membrane [14]. It seems likely 
then that the level of long-chain acylcarnitines is a 
reflection of a flux through the carnitine palmitoyl- 
transferase I, which in turn, may be a consequence of 
changes in the level of long-chain acyl-C!oA (fig.lC) 
and/or changes in the level of malonyl-CoA [3]. It is 
difficult to know how much weight one should put 
on the correlation found between the rate of pahnitate 
oxidation and the level of long-chain acyl-CoA (tig.lB) 
since it was not possible to measure directly the 
extra- and intramitochondrial acyl-CoA. However, 
glucagon causes the increase in the long-chain acyl- 
CoA also under conditions where the flux through 
carnitine pahnitoyltransferase is strongly inhibited by 
lowering the intracellular carnitine concentration 
and/or addition of(t) decanoylcarnitine (table 2). At 
low concentration of carnitine, (t) decanoylcarnitine 
inhibits the oxidation by -75% and causes a small 
increase in long-chain acyl-CoA. Glucagon stimulates 
oxidation and increases the level of long-chain acyl- 
CoA by approximately the same factor in the presence 
and in the absence of the inhibitor. Carnitine does 
not affect the level of long-chain acyl-CoA in liver 
cells of fed rats (table 2). The results strongly suggest 
that the observed increase in the level of long-chain 
acyl-CoA, in the presence of glucagon, represents an 
increase in the extramitochondrial pool. The good 
correlation found between the level of acyl-CoA and 
the rate of oxidation favours therefore the hypothesis 
that the rate of fatty acid oxidation is regulated also 
at a site different from that of carnitine palmitoyl- 
transferase I. If this enzyme was the only rate-limiting 
one and thus regulatory in the oxidation pathway, 
the level of long-chain acylcarnitines and the rates of 
oxidation would be expected to vary independently of 
the long-chain acyl-CoA level. The addition of CAMP 
to the medium perfusing the liver has been shown 
[ 15 J to decrease the activity of the microsomal 
glycerophosphate acyltransferase when assayed in 
vitro. Also phosphatidate phosphohydrolase has been 
reported to be regulatory on the rate of esterifrcation 
and the activity of this enzyme has been found to 
correlate with the level of sn-3-glycerophosphate 
under several conditions [ 16-181. The changes in the 
rate of esterification may condition the level of long- 
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Table 2 
The effect of glucagon on the changes in the level of long-chain acylCoA under different rates of pahnitate oxidation 
-Glucagon 
Oxidation 
products 
Long-chain 
acyl-CoA 
+Glucagon 
Oxidation 
products 
% Changed Long-chain 
acylCoA 
% Changed 
Low carnitine 12.1 (1.0) 0.128 (0.016) 23.4 (I.3)a +93 0.205 (0.018)c +60 
Low carnitine + 
(4) DC 3.1 (0.2) 0.148 (0.018) 5.6 (0.3)a +81 0.230 (0.017)c +55 
High carnitine 21.1 (1.1) 0.132 (0.015) 39.0 (1.5)a +85 0.211 (0.016)c +60 
High carnitine + 
(+) DC 14.6 (0.9) 0.138 (0.014) 24.0 (1.12)~ +64 0.218 (0.012)b +58 
Different from the results obtained in the absence of glucagon with: ap < 0.001, bp < 0.005, $J < 0.02, d% change due to glucagon 
The hepatocytes were preincubated with or without 1 mM (-)carnitine for 45 mm at 37”C, so that the intracellular concentration 
of carnitine was: 0.3-0.5 nmol. mg protein- *, low carnitine; or 1.8-2.5 nmol. mg protein-r, high carnitine. The oxidation prod- 
ucts are presented as a sum of acid-soluble products and r4C0, in nmol palmitate. mg protein-‘; long-chain acylCoA in nmol. 
mg protein- r. (+) Decanoylcarnitine ((+) DC) was added to 1 mM 
chain acyl-CoA and this, in turn, the level of long 
chain acylcarnitines and the rates of oxidation. 
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